-+ 0.00%
-+ 0.00%
-+ 0.00%

Stephens & Co. Maintains Overweight on Vericel, Raises Price Target to $68

Benzinga·11/10/2026 14:07:58
Listen to the news
Stephens & Co. analyst Mason Carrico maintains Vericel (NASDAQ:VCEL) with a Overweight and raises the price target from $55 to $68.